{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:58:50Z","timestamp":1790909930512,"version":"4.1.0"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,1,16]],"date-time":"2004-01-16T00:00:00Z","timestamp":1074211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>The aim of this study was to evaluate the relationship between factor\u00a0VIII (FVIII) levels, measured by chromogenic and clotting assays, and risk of venous thromboembolism (VTE) recurrence. A total of 564 patients underwent clinical follow\u2010up after oral anticoagulant withdrawal (total follow\u2010up\u2003=\u2003924\u00b74\u2003years). Recurrent VTE developed in 39 of 309 (12\u00b76%) patients with a first idiopathic VTE and in 14 of 255 (5\u00b75%) patients whose first event was secondary. In patients with a first idiopathic VTE, the risk of recurrence was more than fivefold higher in patients with FVIII levels exceeding the 90th percentile [chromogenic FVIII: relative risk (RR) 5\u00b743 (95% CI 1\u00b776\u201316\u00b78); clotting FVIII: RR 6\u00b721 (95% CI 1\u00b757\u201324\u00b75)] after adjustment for all possible confounding variables. In patients with a first secondary VTE, the risk of recurrence was slightly higher in patients with high FVIII levels [chromogenic FVIII: RR 2\u00b762 (95% CI 0\u00b734\u201319\u00b79); clotting FVIII: RR 1\u00b774 (95% CI 0\u00b725\u201312\u00b71)], but, given the low number of recurrences, the 95% CI were very large. In conclusion, this study shows that high FVIII levels are associated with increased risk of VTE recurrence in patients with a first idiopathic VTE. Although the measurement of FVIII levels by a specific chromogenic assay might, in principle, be preferred to avoid the risk of aspecific clotting effects, no significant differences in results obtained by chromogenic or clotting methods were found.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04795.x","type":"journal-article","created":{"date-parts":[[2004,12,20]],"date-time":"2004-12-20T18:57:14Z","timestamp":1103569034000},"page":"504-510","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["High plasma levels of factor VIII and risk of recurrence of venous thromboembolism"],"prefix":"10.1111","volume":"124","author":[{"given":"Legnani","family":"Cristina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosmi","family":"Benilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cini","family":"Michela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frascaro","family":"Mirella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guazzaloca","family":"Giuliana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palareti","family":"Gualtiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,1,16]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0"},{"key":"e_1_2_11_3_1","first-page":"271","article-title":"A chromogenic substrate method for detecting and titrating anti\u2010factor VIII antibodies in the presence of lupus anticoagulant","volume":"87","author":"Blanco A.N.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649901"},{"key":"e_1_2_11_5_1","first-page":"14","article-title":"Spectrophotometric method for the assay of human blood coagulation factor VIII","volume":"17","author":"Dieijen G.","year":"1987","journal-title":"Haemostasis"},{"key":"e_1_2_11_6_1","volume-title":"The Statistical Analysis of Failure Time Data","author":"Kalbfleish J.D.","year":"1980"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614985"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0037-1614553","article-title":"Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions","volume":"81","author":"Kamphuisen P.W.","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02091.x"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.21.5.731"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03089.x"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199810000-00009"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90166-3"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613747"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200008173430702"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614254"},{"key":"e_1_2_11_17_1","first-page":"561","article-title":"Analysis of the F8 gene in individuals with high plasma factor VIII:C levels and associated venous thrombosis","volume":"80","author":"Mansvelt E.P.G.","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656061"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613748"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199901000-00002"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1660140"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.13.1546"},{"key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0038-1646581","article-title":"The measurement of haemostatic factors in 16 European laboratories: quality assessment for the Multicentre ECAT Angina Pectoris Study. Report from the European Concerted Action on Thrombosis and Disabilities (ECAT)","volume":"61","author":"Thompson S.G.","year":"1989","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ajcp\/86.3.341","article-title":"Factor VIII activity as measured by an amidolytic assay compared with one\u2010stage clotting assay","volume":"86","author":"Tripodi A.","year":"1986","journal-title":"American Journal of Clinical Pathology"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04795.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04795.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04795.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T03:33:45Z","timestamp":1697427225000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04795.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,16]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04795.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04795.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,16]]},"assertion":[{"value":"2004-01-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}